The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Afeyan Noubar since year 2005.
The trader's CIK number is 1222012.
At the time of the last reporting, Afeyan Noubar was the Director of Seres Therapeutics, Inc. .
(stock ticker symbol MCRB).
See this page for all insider trading activities at Seres Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-06-18||MCRB||Seres Therapeutics, Inc.||Buy||8,888,888||2.25||19,999,998|
|2019-03-04||KLDO||Kaleido Biosciences, Inc.||Buy||933,333||15.00||13,999,995|
|2015-12-09||BGMD||Bg Medicine, Inc.||Sale||46,438||.56||26,005|
|2013-09-25||BIND||Bind Therapeutics, Inc||Buy||20,000||15.00||300,000|
|2009-09-18||HLCS||Helicos Biosciences Corp||Buy||242,931||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Afeyan Noubar (Director of Seres Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.